Tag: Meagher & Flom
Skadden advises Otsuka on potential USD1.2bn biotech buy
Skadden, Arps, Slate, Meagher & Flom is advising Tokyo-based Otsuka Pharmaceutical on its acquisition of clinical-stage biotechnology company
Deals of the Year 2025
A look back at the blockbuster transactions of 2025 as we gallop into the Year of the Horse
Skadden, King & Spalding act on USD1.72bn renewables deal
Skadden and King & Spalding advised on MAM's USD1.72 billion DESRI investment agreement
DLA Piper names new head of real estate in Tokyo
DLA Piper appoints Ed Sheremeta as Tokyo real estate co-head, relocating from Hong Kong where he led the same practice
Skadden, Latham & Watkins steer USD1.12bn biotech sale
Skadden and Latham & Watkins are advising Otsuka Pharmaceutical on its USD1.12 billion acquisition of Jnana Therapeutics
Four firms act on Trial debut in this year’s largest Japan IPO
Trial Holdings, a Japanese discount-store chain, completes global IPO on Tokyo Stock Exchange, raising USD258 million
Seven law firms act on USD8.5bn Reliance-Viacom18-Disney JV
Seven law firms seal Reliance-Viacom18-Disney USD8.5B joint venture deal
